| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
,
,¶
,
,¶,#
,¶
*Division of Nephrology,
Division of General Internal Medicine, University Health Network,
Department of Laboratory Medicine and Pathology,
Clinical Epidemiology and Health Care Research Program, ¶Department of Medicine, and #Department of Health Administration, University of Toronto, Toronto, Ontario, Canada.
Correspondence to Dr. Sarbjit V. Jassal, 200 Elizabeth St, 11EN 225, Toronto, Ontario M5G 2C4, Canada. Phone: 416-340-3196; Fax: 416-586-9827;
ABSTRACT. Transplantation offers superior life expectancy and quality of life compared with dialysis in young patients with end-stage renal failure. However, the initial risks of mortality and morbidity are high. This study used a decision analysis model to evaluate the costs and benefits of kidney transplantation versus continued dialysis for older patients with renal failure. A decision analytic model comparing cadaveric renal transplantation to continued hemodialysis treatment was developed. The base case considered a theoretical cohort of patients aged 65 yr without known comorbidity or contraindications to transplantation who would have to wait 2 yr for a cadaveric transplant. Separate models were constructed for patients with diabetes or cardiovascular disease and for patients receiving an organ after a variety of wait-list times. Probability, utility, and survival data were obtained from published reports and renal registries. For 65-yr-old patients, quality-adjusted life expectancy increased by 1.1 quality-adjusted life years (QALY) at an incremental cost of $67,778 per QALY. Assuming a 2-yr wait-listed time, transplantation remained economically attractive for 70-yr-old patients (incremental cost effectiveness [ICE], $79,359 per QALY) but was less economically attractive for those over 75 yr of age (ICE, $99,553) or for 70-yr-olds with either cardiovascular disease or diabetes (ICE, $126,751 and $161,090 per QALY, respectively). The analytic results were sensitive only to the time spent waiting for the graft. The cost-effectiveness reduced such that the costs associated with one QALY were in excess of $100,000/yr when the probability of a complication was
50% per 3-mo cycle and when the utility of transplantation fell below 0.62. If available within a timely period, transplantation may offer substantial clinical benefits to older patients at a reasonable financial cost. Prolonged waiting times dramatically decrease the clinical benefits and economic attractiveness of transplantation, suggesting that living donor transplantation may be of particular benefit in this population. Email: vanita.jassal@uhn.on.ca
This article has been cited by other articles:
![]() |
E. P. Vamos, G. Csepanyi, M. Zambo, M. Z. Molnar, J. Rethelyi, A. Kovacs, A. Marton, Z. Nemeth, M. Novak, and I. Mucsi Sociodemographic factors and patient perceptions are associated with attitudes to kidney transplantation among haemodialysis patients Nephrol. Dial. Transplant., November 30, 2008; (2008) gfn660v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Earnshaw, C. N. Graham, W. D. Irish, R. Sato, and M. A. Schnitzler Lifetime Cost-Effectiveness of Calcineurin Inhibitor Withdrawal After De Novo Renal Transplantation J. Am. Soc. Nephrol., September 1, 2008; 19(9): 1807 - 1816. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Wu, I. Evans, R. Joseph, R. Shapiro, H. Tan, A. Basu, C. Smetanka, A. Khan, J. McCauley, and M. Unruh Comorbid Conditions in Kidney Transplantation: Association with Graft and Patient Survival J. Am. Soc. Nephrol., November 1, 2005; 16(11): 3437 - 3444. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Villar, M. Rabilloud, F. Berthoux, P. Vialtel, M. Labeeuw, and C. Pouteil-Noble A multicentre study of registration on renal transplantation waiting list of the elderly and patients with type 2 diabetes Nephrol. Dial. Transplant., January 1, 2004; 19(1): 207 - 214. [Abstract] [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673